94530
Valeric acid
puriss., ≥99.0% (GC)
Synonym(s):
n-Valeric acid, Pentanoic acid
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Linear Formula:
CH3(CH2)3COOH
CAS Number:
Molecular Weight:
102.13
EC Number:
203-677-2
UNSPSC Code:
12352100
MDL number:
Beilstein/REAXYS Number:
969454
vapor density
3.5 (vs air)
vapor pressure
0.15 mmHg ( 20 °C)
grade
puriss.
assay
≥99.0% (GC)
autoignition temp.
707 °F
expl. lim.
7.6 %
refractive index
n20/D 1.408
bp
110-111 °C/10 mmHg (lit.), 185 °C (lit.)
mp
−20-−18 °C (lit.)
density
0.939 g/mL at 25 °C (lit.)
SMILES string
CCCCC(O)=O
InChI
1S/C5H10O2/c1-2-3-4-5(6)7/h2-4H2,1H3,(H,6,7)
InChI key
NQPDZGIKBAWPEJ-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Gamze Bora-Tatar et al.
Bioorganic & medicinal chemistry, 17(14), 5219-5228 (2009-06-13)
In the light of known HDAC inhibitors, 33 carboxylic acid derivatives were tested to understand the structural requirements for HDAC inhibition activity. Several modifications were applied to develop the structure-activity relationships of carboxylic acid HDAC inhibitors. HDAC inhibition activities were
Sean Ekins et al.
Drug metabolism and disposition: the biological fate of chemicals, 38(12), 2302-2308 (2010-09-17)
Drug-induced liver injury (DILI) is one of the most important reasons for drug development failure at both preapproval and postapproval stages. There has been increased interest in developing predictive in vivo, in vitro, and in silico models to identify compounds
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service